Privia Health Group Hits New 52-Week High at $27.86

Privia Health Group, Inc. has reached a significant milestone by hitting a new 52-week high of USD 27.86 on July 10, 2026. This achievement underscores the company's strong performance in the insurance industry, particularly as it has recorded a remarkable 62.18% increase over the past year, significantly outperforming the S&P 500, which has seen a gain of 20.62% during the same period. With a market capitalization of USD 2,476 million, Privia Health Group is classified as a small-cap company. The stock currently has a price-to-earnings (P/E) ratio of 108.00, reflecting its valuation in the market. Additionally, the company has a price-to-book ratio of 3.36 and a return on equity of 3.11%. Notably, Privia Health Group does not offer a dividend yield, and its debt equity ratio indicates a unique financial structure. The stock's previous 52-week low was recorded at USD 18.77, highlighting the significant upward movement in its price. This performance reflects the company's position within the insurance sector and its ability to navigate market dynamics effectively.